Memory performance in polyvalent MDMA (ecstasy) users who continue or discontinue MDMA use

Drug and Alcohol Dependence

Volumn 78, Issue 3, 2005, Pages 317-323

  Gouzoulis Mayfrank, Euphrosyne ^a   Fischermann, Thomas ^a   Rezk, Markus ^b   Thimm, Bastian ^b   Hensen, Gernot ^b   Daumann, Joerg ^a  

^a UNIVERSITY OF COLOGNE   (Germany)

^b UNIVERSITY HOSPITAL RWTH AACHEN   (Germany)

Author keywords

Cognition; Ecstasy; MDMA; Memory; Neurotoxicity; Serotonin

Indexed keywords

3,4 METHYLENEDIOXYMETHAMPHETAMINE; NEUROTOXIN;

ADULT; ARTICLE; COGNITION; CONTROLLED STUDY; DRUG USE; DRUG UTILIZATION; DRUG WITHDRAWAL; FEMALE; HUMAN; MALE; MEMORY DISORDER; NEUROTOXICITY; PRIORITY JOURNAL; SEROTONINERGIC NERVE CELL; TASK PERFORMANCE; TIME SERIES ANALYSIS;

ADULT; BRAIN; CROSS-SECTIONAL STUDIES; DEMOGRAPHY; FEMALE; FOLLOW-UP STUDIES; HALLUCINOGENS; HUMANS; MALE; MEMORY DISORDERS; N-METHYL-3,4-METHYLENEDIOXYAMPHETAMINE; NEUROPSYCHOLOGICAL TESTS; SEVERITY OF ILLNESS INDEX; SUBSTANCE-RELATED DISORDERS;

ANIMALIA;

EID: 18844425775     PISSN: 03768716     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.drugalcdep.2004.12.002     Document Type: Article

References (41)

1. C. Back-Madruga, K.B. Boone, L. Chang, C.S. Grab, A. Lee, H. Nations, and R.E. Poland Neuropsychological effects of 3,4-methylenedioxymethamphetamine (MDMA or ecstasy) in recreational users Clin. Neuropsychol. 17 2003 446 459
2. G. Bäumler Lern- und Gedachtnistest (Learning and memory test) LGT-3 1974 Verlag fur Psychologie Hogrefe Göttingen
3. S. Bhattachary, and J.H. Powell Recreational use of 3,4- methylenedioxymethamphetamine (MDMA) or "ecstasy": evidence for cognitive impairment Psychol. Med. 31 2001 647 658
4. K.I. Bolla, U.D. McCann, and G.A. Ricaurte Memory impairment in abstinent MDMA ("ecstasy") users Neurology 51 1998 1532 1537
5. M.-C. Buhot, S. Martin, and Segu Role of serotonin in memory impairment Ann. Med. 32 2000 210 221
6. V.H. Curran Is MDMA (ecstasy) neurotoxic in humans? An overview of evidence and of methodological problems in research Neuropsychobiology 42 2000 34 41
7. H.V. Curran, and R.A. Travill Mood and cognitive effects of ±3,4-methylenedioxymeth-amphetamine (MDMA, "ecstasy"): week-end, high" followed by mid-week low Addiction 92 1997 821 831
8. R.I. Dafters, F. Duffy, P.J. O'Donnell, and C. Bouquet Level of use of 3,4-methylene-dioxymethamphetamine (MDMA or ecstasy) in humans correlates with EEG power and coherence Psychopharmacology 145 1999 82 90
9. R.I. Dafters, R. Hoshi, and A.C. Talbot Contribution of cannabis and MDMA ("ecstasy") to cognitive changes in long-term polydrug users Psychopharmacology 173 2004 405 410
10. J. Daumann, G. Hensen, B. Thimm, M. Rezk, B. Till, and E. Gouzoulis-Mayfrank Self-reported psychopathological symptoms in abstinent recreational ecstasy (MDMA) users are mainly associated with regular cannabis use: further evidence from a combined cross-sectional/longitudinal investigation Psychopharmacology 173 2004 398 404
11. C. Fischer, G. Hatzidimitriou, J. Wlos, J. Katz, and G. Ricaurte Reorganization of ascending 5-HAT axon projections in animals previously exposed to the recreational drug 3,4-methylenedioxymethamphetamine (MDMA, ecstasy) J. Neurosci. 15 1995 5476 5485
12. E. Gouzoulis-Mayfrank, J. Daumann, F. Tuchtenhagen, S. Pelz, S. Becker, H.-J. Kunert, B. Fimm, and H. Sass Impaired cognitive performance in drug-free recreational ecstasy (MDMA) users J. Neurol. Neurosurg. Psychiat. 68 2000 719 725
13. E. Gouzoulis-Mayfrank, B. Thimm, M. Rezk, G. Hensen, and J. Daumann Memory impairment suggests hippocampai dysfunction in abstinent ecstasy (MDMA) users Progr. Neuro-Psychopharmacol. Biol. Psychiat. 27 2003 819 827
14. A.R. Green, A.O. Mechan, J.M. Elliott, E. O'Shea, and M.I. Colado The pharmacology and clinical pharmacology of 3,4-methylenedioxymethamphetamine (MDMA, "ecstasy") Pharmacol Rev. 55 2003 463 508
15. K.L. Hanson, and M. Luciana Neurocognitive function in users of MDMA: the importance of clinically significant patterns of use Psychol. Med. 34 2004 229 246
16. G. Hatzidimitriou, U.D. McCann, and G. Ricaurte Altered serotonin innervation patterns in the forebrain of monkeys treated with ±3,4-methylenedioxymethamphetamine seven years previously: factors influencing abnormal recovery J. Neurosci. 19 1999 5096 5107
17. J.H. Krystal, and L.H. Price Chronic 3,4-methylenedioxymethamphetamine (MDMA) use: effects on mood and neuropsychological function? Am. J. Drug Alcohol Abuse 18 1992 331 341
18. U.D. McCann, Z. Szabo, U. Scheffel, R.F. Dannals, and G.A. Ricaurte Positron emission tomographic evidence of toxic effect of MDMA ("ecstasy") on brain serotonin neurons in human beings Lancet 352 Suppl. 9138 1998 1433 1437
19. U.D. McCann, M. Mertl, V. Eligulashvili, and G.A. Ricaurte Cognitive performance in 3,4-methylenedioxymethamphetamine (MDMA, ecstasy) users: a controlled study Psychopharmacology 143 1999 417 425
20. U.D. McCann, V. Eligulashvili, and G.A. Ricaurte 3,4- methylenedioxymethamphetamine (ecstasy)-induced serotonin neurotoxicity: clinical studies Neuropsychobiology 42 2000 11 16
21. K. McCardle, S. Luebbers, J.D. Carter, R.J. Croft, and C. Stough Chronic MDMA (ecstasy) use, cognition and mood Psychopharmacology 173 2004 434 439
22. M.J. Morgan Recreational use of "ecstasy" (MDMA) is associated with elevated impulsivity Neuropsychopharmacology 19 1998 252 264
23. M.J. Morgan Memory deficits associated with recreational use of "ecstasy" (MDMA) Psychopharmacology 141 1999 30 36
24. A.C. Parrott, and J. Lasky Ecstasy (MDMA) effects upon mood and cognition: before, during and after a Saturday night dance Psychopharmacology 139 1998 261 268
25. A.C. Parrott Human research on MDMA (3,4-methylenedioxymethamphetamine) neurotoxicity: cognitive and behavioural indices of change Neuropsychobiology 42 2000 17 24
26. C.X. Poulos, J.L. Parker, and A.D. Le Desfenfluramine and 8-OH-DPAT modulate impulsivity in a delay-of-reward paradigm: implications for a correspondence with alcohol consumption Behav. Pharmacol. 7 1996 395 399
27. L. Reneman, J. Booij, B. Schmand, W. van den Brink, and B. Gunning Memory disturbances in, ecstasy users are correlated with an altered brain serotonin neurotransmission Psychopharmacology 148 2000 322 324
28. L. Reneman, J. Lavalaye, B. Schmand, F.A. de Wolff, W. van den Brink, G.J. den Heeten, and J. Booij Cortical serotonin transporter density and verbal memory in individuals who stopped using 3,4-methylenedioxymethamphetamine (MDMA or "Ecstasy") Arch. Gen. Psychiat. 58 2001 901 906
29. G.A. Ricaurte, A.L. Martello, J.L. Katz, and M.B. Martello Lasting effects of MDMA on central serotonergic neurons in nonhuman primates: neurochemical observations J. Pharmacol. Exp. Ther. 261 1992 616 622
30. G.A. Ricaurte, J. Yuan, and D.U. McCann 3,4-methylenedioxymethamphetamine (ecstasy)-induced serotonin neurotoxicity: studies in animals Neuropsychobiology 42 2000 5 10
31. G. Richter-Levin, and M. Segal Serotonin, aging and cognitive functions of the hippocampus Rev. Neurosci. 7 1996 103 113
32. W.J. Riedel, T. Klaasen, N.E.P. Deutz, A. van Someren, and H.M. van Praag Tryptophan depletion in normal volunteers produces selective impairment in memory consolidation Psychopharmacology 141 1999 362 369
33. J. Rodgers Cognitive performance amongst recreational users of "ecstasy" Psychopharmacology 151 2001 19 24
34. J. Rodgers, T. Buchanan, A.B. Scholey, T.M. Heffernan, J. Ling, and A.C. Parrott Patterns of drug use and the influence of gender on self-reports of memory ability in ecstasy users: a web-based study J. Psychopharmacol. 17 2003 389 396
35. U. Tewes HAWIE-R. Hamburg-Wechsler Intelligenz test fur Erwachsene/Revision 2nd ed. 1991 Huber Bern
36. R. Thomasius, K. Petersen, R. Buchert, B. Andresen, P. Zapletalova, L. Wartberg, B. Nebeling, and A. Schmoldt Mood, cognition and serotonin transporter availability in current and former ecstasy (MDMA) users Psychopharmacology 167 2003 85 96
37. R.J. Verkes, H.J. Gijsman, R.C. Pieters, S. de Visser, M. Kuijpers, J.M. Pennings, D. de Bruin, G. Van de Winjngaart, J.M.A. Van Grven, and A.F. Cohen Cognitive performance and serotonergic function in users of ecstasy Psychopharmacology 153 2001 196 202
38. M. Wareing, J.E. Fisk, and P.N. Murphy Working memory deficits in current and previous users of MDMA ("ecstasy") Br. J. Psychol. 91 2000 181 188
39. M. Wareing, P.N. Murphy, and J.E. Fisk Visuospatial memory impairments in users of MDMA ("ecstasy") Psychopharmacology 173 2004 391 397
40. K.K. Zakzanis, and D.A. Young Memory impairment in abstinent MDMA ("ecstasy") users: a longitudinal investigation Neurology 56 2001 966 969
41. Zimmermann, P., Fimm, B., 1995. Test for Attentional Performance (TAP), PsyTest, Herzogenrath.